Zhang HY

No ORCID on file · 6 papers in corpus · active 2014-2026

Study types

  • other 3
  • article 2
  • rct 1

Condition tags

  • endometriosis 4
  • dysmenorrhea 2
  • adenomyosis 2
  • endometrioma 1
rct 2026
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20250421-00161

Objective: To evaluate the efficacy and safety of triptorelin acetate microspheres for injection compared with triptorelin acetate for injection in the treatment of endometriosis. Methods: A total of 392 patients with endometriosis were pro…

other 2025
Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-025-01130-8

BACKGROUND: Endometriosis (EMs) is a condition characterized by the growth of endometrial tissue outside the uterine cavity. Although this condition is benign, it has cancer-like features. N6-methyladenosine (m6A) is a common RNA modificati…

other 2024
Immunology ·doi:10.1111/imm.13786

Endometriosis is defined as an oestrogen-dependent and inflammatory gynaecological disease of which the pathogenesis remains unclear. This study aimed to investigate the cellular heterogeneity and reveal the effect of CD8+ T cells on the pr…

article 2022
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20211229-00759

and anemia.

other 2022
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20220520-00336

Objective: To investigate the efficacy and safety of dienogest (DNG) alone and gonadotropin-releasing hormone agonist (GnRH-a) combined with DNG sequential treatment to adenomyosis. Methods: The clinical data of 110 patients with adenomyosi…

article 2014
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2014.10.022

ObjectivesDifferent gonadotropin-releasing-hormone agonist (GnRH-a) formulations with different potency and associated side effects, therefore, different compliance and persistence of therapy. This study was to evaluate the difference of ho…